Company & Sponsor Intelligence
Nantes University Hospital
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials6
Recruiting0
Completed2
Countries1
Therapeutic footprint
adhdother_psychiatryparkinsonsstroke
Indexed studies
NCT03230526Identification of a Biomarker Predictive of Evolution of Parkinson Disease
parkinsons · FrancePHASE2
parkinsons · FrancePHASE2
NCT02236260Evaluation of the Benefit Provided by Acupuncture During a Surgery of Deep Brain Stimulation
parkinsons · FranceNA
parkinsons · FranceNA
NCT04857788Program of Digital Accompaniment to Optimize Homework Performances and Increase Familial Quality of Life in 9 to 16 Years Children With ADHD
adhd · FranceNA
adhd · FranceNA
NCT00872443Interest of Occlusion of Permeable Foramen Ovale After a Cryptogenic Cerebrovascular Accident (CVA)
stroke · FranceCOMPLETED
stroke · FranceCOMPLETED
NCT03754166Feasibility of Constraint-induced Therapy Combined With Visual-spatial Cueing Strategy in Patients With Acute Stroke
stroke · FranceNA
stroke · FranceNA
NCT04358042PSYCHIATRIC Disorders and Covid-19
other_psychiatry · FranceTERMINATED
other_psychiatry · FranceTERMINATED
Intelligence layer updated: 2026-10-14 06:11:28.884102+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →